Васкулит
Jing He, Ruijun Zhang, Miao Shao et al.
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.Реестр клинических исследований США. 1 апреля 2023 г.
Miao Miao, Xian Xiao, Jiayi Tian et al.
Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study.Реестр клинических исследований США. 3 апреля 2023 г.
Graßhoff H, Comdühr S, Monne LR et al.
Front. Immunol., 01 April 2021. Sec. Immunological Tolerance and Regulation. Volume 12. — 2021.
Chunmiao Zhao, Yanfang Chu, Zhaoyun Liang et al.
Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients.Zhao et al. BMC Immunology. — 2019. — P. 20:32.
Частота инфекций при лечении низкими дозами ИЛ-2 у больных СКВ.
Реестр клинических исследований США. Клиническое испытание NCT04136106. Peking University People’s Hospital. 21 октября 2019 г.
Abbas A.K., Trotta E., Simeonov D.R., Marson A., Bluestone J.A.
Интерлейкин-2: механизмы регуляции и перспективы терапии.
Science Immunology. — 2018. — Vol. 3. — Issue 25. — Eaat 1482.
Abbas A.K., Trotta E., Simeonov D.R., Marson A., Bluestone J.A.
Revisiting IL-2: Biology and therapeutic prospects.
Science Immunology. — 2018. — Vol. 3. — Issue 25. — Eaat 1482.
Zhen Zhao, Xiaojuan Zhang, Lili Su et al.
Fine tuning subsets of CD4+ T cells by low-dosage of IL-2 and a new therapeutic strategy for autoimmune diseases.International Immunopharmacology. — Volume 56. — 2018. — Pages 269-276.
Jing He, Xia Zhang, Yunbo Wei et al.
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosusNat Med. 2016 Sep;22(9):991-3. doi: 10.1038/nm.4148. Epub 2016 Aug 8. PMID: 27500725.
Zhanguo Li
Пилотное исследование низких доз hrIL-2 для лечения системной красной волчанкиРеестр клинических исследований США. Клиническое испытание NCT02465580. Peking University People’s Hospital. 21 октября 2019 г.
David Saadoun, Michelle Rosenzwajg, Florence Joly et al.
New England Journal of Medicine. — 2011. — 365(22):2067-77.
Kharkevich G.Yu., Tsimafeyeu I.V., Demidov L.V., Semenkova E.N.
Management of paraneoplastic vasculitis by interleukin-2 in patients with metastatic renal cell carcinoma (MRCC).
UICC World Cancer Congress 2006. EDUCATION / ABSTRACT BOOK. Washington, 2006. Abstr. N 11-41. P. 102.
Xinyu Zheng,Rui Su,Fangyuan Hu et al.
Low-dose IL-2 therapy restores imbalance between Th17 and regulatory T cells in patients with the dermatomyositis combined with EBV/CMV viremia.Autoimmunity Reviews. — 2022. — Vol. 21, November, Issue 11, , P. 103186.